We have worked with pharmaceutical and life sciences organisations through product launches, market access strategy, commercial transformation and the regulatory complexity that sits across every major decision. We understand the relationship between medical affairs, commercial, market access and regulatory — and we know how to design operating models and change programmes that work within those constraints rather than against them. Our practitioners have held senior commercial roles inside the industry, not just advised it from the outside.
Pre-launch commercial strategy, market access planning and the positioning work that determines success before a single rep is hired.
Launch readiness, commercial model design and the cross-functional coordination to maximise the critical first 90 days.
Payer strategy, HTA submissions and the evidence generation plan that gets products reimbursed at the right price.
Building the commercial infrastructure — from CRM to patient services to supply chain — that lets biotech and specialty pharma companies scale.